Epiminder America, Inc.

This study follows 210 people with epilepsy who already have a Minder device implanted. The device helps doctors make better treatment decisions after a seizure or other actionable event. Participants will be monitored every six months for two years to see how the device improves…

This study tests a small device placed under the scalp that records brain activity in people with epilepsy whose standard tests were unclear. About 210 adults with drug-resistant epilepsy will either get the device or continue usual care. The goal is to see if the device helps do…